Don't miss our US IP events next week

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Don't miss our US IP events next week

I’ll be in San Jose next week for two Managing IP events: our International Women’s Leadership Forum is on Tuesday, and the European Patent Reform Forum takes place the day after (my colleague Michael Loney is hosting another on Friday in New York)

My colleagues have put together very interesting programmes for both, with a great line-up of in-house and private practice speakers.

womens20forum.jpg

The Women’s Leadership Forum is the second such event we have hosted, after our inaugural one in June in New York (pictured). The sessions will be led by leading women IP practitioners who will be speaking on topics including litigation and licensing trends, dealing with NPEs, biotechnology, IP protection and social media, and IP developments in Canada and Europe. Panellists include in-house lawyers from Facebook, Twitter, StubHub, SAP, Gilead, Toyota, Nokia and CBS (among others) as well as some of the top US, Canadian and UK private practice lawyers.

Chief Magistrate Judge Elizabeth D Laporte of the Northern District of California is giving the keynote address and the final session will see a panel of in-house counsel and law firm partners offering advice on progressing your IP career. The event is aimed at women at all stages of their career, from junior associates to senior partners.

The European Patent Reform Forum aims to give US in-house counsel, and their US private practice advisers, a thorough primer in the changes taking place in Europe affecting patent prosecution and enforcement.

Although the first Unitary Patent is not slated to be issued until next year at the earliest, savvy companies are already considering their strategies: weighing up the likely costs and benefits (financial and strategic) of applying for Unitary Patents; and considering whether to opt in or out of the Unified Patent Court system.

An excellent group of speakers including lawyers from the EPO, in-house counsel and some of the European private practitioners who have followed the machinations of EU patent reform most closely will offer advice for developing your own strategies.

You can still register for both events online. They are both free for in-house counsel and R&D professionals. We did temporarily close registration for the Women’s Forum but have now managed to secure a larger venue at the Fairmont to cope with demand and should be able to squeeze a few more people in.

If you are coming along to one (or both) of the events then I look forward to seeing you there (do come and say hello). If you can’t make it on the day then you can follow the proceedings on Twitter using @managingip. Those of you on the East Coast can find out more about the New York European Patent Reform Forum taking place on Friday here.

more from across site and SHARED ros bottom lb

More from across our site

News of Avanci hiring a senior vice president and the EPO teaming up with a French AI startup were also among the top talking points
Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Gift this article